• Columns
  • Intestinal Fortitude - a Column by Emmeline Olson

Prednisone and Crohn’s May Break My Bones

Despite being a rough-and-tumble tomboy as a child, I never broke any bones until my 40s. In 2015, I broke…

  • News

Study Links Etanercept with Increased IBD Risk

Treatment with etanercept may increase a person's risk of developing inflammatory bowel disease (IBD), a study suggests. The study, "Increased…

  • Columns
  • Finding the Silver Linings - a column by Lisa Burks

What Tests Are Used to Diagnose a Crohn’s Flare-up?

Those who live with Crohn’s disease know that at times symptoms become more severe, which is known as a Crohn’s…

  • News

Plant-based Diet Beneficial to Crohn’s Patients, Case Study Suggests

A high-fiber diet rich in plant proteins and whole foods may be effective to treat Crohn’s disease, according to a…

  • News

Th17 Immune Cells Raise Risk of Severe C. difficile in Colitis Patients, Study Shows

Patients with colitis are particularly susceptible to infection by the toxin-producing bacteria Clostridium difficile, but the reason remained unknown. Now,…

  • Columns
  • Intestinal Fortitude - a Column by Emmeline Olson

Cyberchondria Anxiety: When Self-diagnosis Becomes Self-defeating

A couple of months ago, I wrote about my first appointment with my new nephrologist, Dr. Mididoddi, and the possibility…

  • News

Study Links Depression to Increased IBD Activity, Faulty Emotional Recognition

Depression is linked to increased disease activity and fewer positive emotional recognition biases in people with inflammatory bowel disease (IBD),…

  • News

Non-invasive Test for Leaky Gut Could Help Diagnose IBD, Study Says

A novel test that measures the concentration of gut bacterial products in a person's blood and stool may become a…

  • News

Costs of Care for Crohn’s, UC, Have Increased Over Last Five Years in US, Study Says

The costs of care for people with inflammatory bowel disease (IBD) living in the U.S. have steadily increased over the…

  • News

Therapy Candidate IMU-838 Shows Strong Activity in Preclinical Models of UC, Immunic Announces

IMU-838, Immunic Therapeutics' lead therapy candidate for the treatment of ulcerative colitis (UC) and relapsing-remitting multiple sclerosis (RRMS), shows strong…